SCHEMBL8873387

SCHEMBL8873387

O=C(OCc1ccccc1)C(Cc1ccccc1)OS(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.52
ITGB7 P26010 1/20 0.52
P2RX7 Q99572 1/20 0.47
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 3/20 0.45
NPC1 O15118 2/20 0.45
CTSL P07711 1/20 0.45
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP19A1 P11511 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8873376 1.00 ITGA4 (0.52) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL180029 0.88 NPC1 (0.49) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL180028 0.88 NPC1 (0.49) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL28690909 0.88 KMT2A (0.47) ALDH1A1L3MBTL1RAB9ANPC1TP53
SCHEMBL5968987 0.88 KMT2A (0.47) ALDH1A1L3MBTL1RAB9ANPC1TP53
SCHEMBL8874777 0.87 CTSL (0.47) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL8874785 0.87 CTSL (0.47) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL8873243 0.83 TDP1 (0.41) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL8873229 0.83 TDP1 (0.41) ITGA4ITGB7P2RX7ALDH1A1L3MBTL1
SCHEMBL29562229 0.81 KMT2A (0.47) ALDH1A1L3MBTL1RAB9ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5683997-A MODULATION OF AT2 RECEPTOR CIBA-GEIGY CORPORATION (US) 1997-11-04 US disclosed
US-5610153-A ENZYME INHIBITORS; TREATMENT OF VASCULAR PROLIFERATION DISORDERS, STERILITY DYSFUNCTION, DYSMENORRHEA CIBA-GEIGY CORPORATION (US) 1997-03-11 US disclosed